About this trial
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing elective upper endoscopy with gastroenterology team
Disqualifiers
Urgent or emergent procedure
Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
Upper GI barium study performed in past 24 hours.
Gastroparesis
Trial design
Single group
Treatments tested in this trial
Modified Fasting Guidelines
Other interventionPatients will follow a full-liquid diet 48 hours prior to their procedure, clear liquid diet 24 hours prior to their procedure, and nothing by mouth (NPO) after midnight on the day of their procedure
Treatment groups
Trial outcomes
Primary outcomes
Gastric contents
Number of patients who were found to have gastric contents within the stomach during the upper endoscopy.
Secondary outcomes
Diagnosis of aspiration within 72 hours of procedure
Whether or not a patient was diagnosed with aspiration will be determined via chart review for 72 hours after the completion of upper endoscopy. A note documenting aspiration or an ICD code associated with aspiration will indicate that this outcome occurred.
Aspiration pneumonitis diagnosis postoperatively
The number of patients who have a diagnosis of aspiration pneumonitis, as identified by the presence of ICD codes J69.0 or J69.8, postoperatively.
Postprocedural ICU admission
The number of patients who were admitted to the ICU immediately after upper endoscopy.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.